nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aberrant alpha and gamma oscillations ex vivo after single application of the NMDA receptor antagonist MK-801
|
Lemercier, Clément E. |
|
2017 |
188 |
C |
p. 118-124 |
artikel |
2 |
Abnormal prefrontal and parietal activity linked to deficient active binding in working memory in schizophrenia
|
Grot, Stéphanie |
|
2017 |
188 |
C |
p. 68-74 |
artikel |
3 |
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
|
D'Addario, Claudio |
|
2017 |
188 |
C |
p. 132-140 |
artikel |
4 |
Are current labeling terms suitable for people who are at risk of psychosis?
|
Kim, Sung-Wan |
|
2017 |
188 |
C |
p. 172-177 |
artikel |
5 |
Autism Spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal study
|
Fiksinski, A.M. |
|
2017 |
188 |
C |
p. 59-62 |
artikel |
6 |
Cerebral blood flow autoregulation is impaired in schizophrenia: A pilot study
|
Ku, Hsiao-Lun |
|
2017 |
188 |
C |
p. 63-67 |
artikel |
7 |
Clozapine and long-acting injectable antipsychotic combination: A retrospective one-year mirror-image study
|
Souaiby, Lama |
|
2017 |
188 |
C |
p. 89-91 |
artikel |
8 |
Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome
|
Hooper, Stephen R. |
|
2017 |
188 |
C |
p. 33-34 |
artikel |
9 |
CYP2D6 polymorphisms are associated with effects of risperidone on neurocognitive performance in schizophrenia
|
Zeng, Lei |
|
2017 |
188 |
C |
p. 50-51 |
artikel |
10 |
Deep dreaming, aberrant salience and psychosis: Connecting the dots by artificial neural networks
|
Keshavan, Matcheri S. |
|
2017 |
188 |
C |
p. 178-181 |
artikel |
11 |
Different alterations in brain functional networks according to direct and indirect topological connections in patients with schizophrenia
|
Park, Chang-hyun |
|
2017 |
188 |
C |
p. 82-88 |
artikel |
12 |
Diminished auditory sensory gating during active auditory verbal hallucinations
|
Thoma, Robert J |
|
2017 |
188 |
C |
p. 125-131 |
artikel |
13 |
Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients?
|
Mueller, Daniel R. |
|
2017 |
188 |
C |
p. 92-97 |
artikel |
14 |
Early motor developmental milestones and schizophrenia: A systematic review and meta-analysis
|
Filatova, S |
|
2017 |
188 |
C |
p. 13-20 |
artikel |
15 |
Editorial Board
|
|
|
2017 |
188 |
C |
p. IFC |
artikel |
16 |
Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis – Results of the randomized controlled Vienna omega-3 study
|
Smesny, Stefan |
|
2017 |
188 |
C |
p. 110-117 |
artikel |
17 |
Episodic memory functions in first episode psychosis and clinical high risk individuals
|
Greenland-White, Sarah E. |
|
2017 |
188 |
C |
p. 151-157 |
artikel |
18 |
Factors associated with drug attitude in patients with schizophrenia spectrum disorders
|
Harber, Lillian |
|
2017 |
188 |
C |
p. 185-186 |
artikel |
19 |
Female schizophrenia patients and risk of breast cancer: A population-based cohort study
|
Wu Chou, Ana Isabel |
|
2017 |
188 |
C |
p. 165-171 |
artikel |
20 |
In This Issue September 2017
|
DeLisi, Lynn E. |
|
2017 |
188 |
C |
p. 1-2 |
artikel |
21 |
Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome
|
Ramanathan, Seetha |
|
2017 |
188 |
C |
p. 35-41 |
artikel |
22 |
Meta-analysis of functional magnetic resonance imaging studies of timing and cognitive control in schizophrenia and bipolar disorder: Evidence of a primary time deficit
|
Alústiza, Irene |
|
2017 |
188 |
C |
p. 21-32 |
artikel |
23 |
Morphological brain changes associated with negative symptoms in patients with 22q11.2 Deletion Syndrome
|
Mihailov, Angeline |
|
2017 |
188 |
C |
p. 52-58 |
artikel |
24 |
Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study
|
Mekori-Domachevsky, Ehud |
|
2017 |
188 |
C |
p. 42-49 |
artikel |
25 |
Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects
|
Emsley, Robin |
|
2017 |
188 |
C |
p. 144-150 |
artikel |
26 |
Peripheral biomarker signatures of bipolar disorder and schizophrenia: A machine learning approach
|
Pinto, Jairo Vinícius |
|
2017 |
188 |
C |
p. 182-184 |
artikel |
27 |
Predictors of current functioning and functional decline in schizophrenia
|
Joseph, Jamie |
|
2017 |
188 |
C |
p. 158-164 |
artikel |
28 |
Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications
|
Ali, Fahmy T. |
|
2017 |
188 |
C |
p. 98-109 |
artikel |
29 |
Resting-state functional connectivity in medication-naïve schizophrenia patients with and without auditory verbal hallucinations: A preliminary report
|
Chang, Xiao |
|
2017 |
188 |
C |
p. 75-81 |
artikel |
30 |
The effects of oxytocin and galantamine on objectively-defined vocal and facial expression: Data from the CIDAR study
|
Cohen, Alex S. |
|
2017 |
188 |
C |
p. 141-143 |
artikel |
31 |
The feasibility and clinical benefits of improving facial affect recognition impairments in schizophrenia: Systematic review and meta-analysis
|
Bordon, Natalie |
|
2017 |
188 |
C |
p. 3-12 |
artikel |